Johns Hopkins ABX Guide
Didanosine
INDICATIONS
FDA
FDA
- Treatment of HIV infection in combination with other antiretrovirals.
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: May 1, 2017
Citation
Smith, Janessa, and Paul A Pham. "Didanosine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine.
Smith J, Pham PA. Didanosine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine. Accessed May 31, 2023.
Smith, J., & Pham, P. A. (2017). Didanosine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine
Smith J, Pham PA. Didanosine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2023 May 31]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Didanosine
ID - 540170
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/05/01/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540170/all/Didanosine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
